Delivery Order SPE2DB24D2109-SPE2DB25FHXNG
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 14, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30, with a ceiling value of $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The contract is set to complete by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging of 30-count bottles. This is a firm fixed price delivery order with a ceiling value of $13,846.97 and an ultimate completion date of August 18, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 4, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Vyndamax is a branded pharmaceutical used in the treatment of cardiac amyloidosis...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency for the supply of Vyndamax 61 mg capsules in unit dose packs of 30, with a ceiling value of $13,846.97. This firm fixed-price delivery order, which is not set aside for any particular business category, is scheduled for ultimate completion by September 3, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on July 28, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $13,846.97 and an ultimate completion date of August 18, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). The contract, with an ultimate completion date of August 20, 2025, employs firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXNGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vyndamax 61 mg capsule unit dose packaging in quantities of 30, valued at $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set for ultimate completion by August 14, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a prescription medication used in the treatment of transthyretin amyloidosis, a rare genetic disorder affecting the nervous system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to serve as a global pharmaceutical supplier for military healthcare programs, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitive awards through DLA demonstrates its established capability to meet federal medical procurement requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/24/25 |